Changes in Choroidal Thickness After Panretinal Photocoagulation: A Retrospective Study from Al Qassim, Saudi Arabia

A retrospective study from the Al Qassim region of Saudi Arabia has found that panretinal photocoagulation (PRP), a standard treatment for diabetic retinopathy, leads to a significant reduction in choroidal thickness six months after the procedure.

The study, published in SCIRP Open Access, evaluated changes in choroidal thickness before and six months after PRP in patients with diabetic retinopathy. Researchers observed a clear decrease in choroidal thickness following the laser treatment, suggesting that PRP may affect the vascular structure of the choroid over time.

These findings align with prior research indicating that PRP can influence choroidal hemodynamics. One study published in PubMed noted that choroidal thickness decreased 12 weeks after PRP, which researchers attributed to reduced choroidal vascular permeability or atrophy of choroidal vessels. Another study reported similar observations, linking PRP to structural changes in the choroid that may reflect alterations in blood flow or vascular integrity.

Additional evidence from a Springer publication supports these results, showing that subfoveal choroidal thickness was significantly lower at one, three, and six months post-PRP compared to baseline measurements. This consistent pattern across multiple studies strengthens the conclusion that PRP induces measurable and lasting changes in the choroid.

The choroid, a layer of blood vessels and connective tissue between the retina and sclera, plays a critical role in supplying oxygen and nutrients to the outer retina. Alterations in its thickness may therefore have implications for retinal health, particularly in patients with diabetes who are already at risk for vascular complications.

While PRP remains essential for preventing vision loss in proliferative diabetic retinopathy by reducing retinal ischemia and inhibiting abnormal blood vessel growth, its impact on the choroid highlights the need for further investigation into the treatment’s broader anatomical effects. Understanding these changes could help refine monitoring strategies and improve long-term outcomes for patients undergoing repeated or intensive laser therapy.

The researchers emphasized that although the functional consequences of choroidal thinning after PRP are not yet fully understood, the structural changes observed warrant attention in clinical follow-up. They recommended incorporating choroidal thickness measurements into routine imaging protocols for patients receiving PRP to better track ocular changes over time.

As diabetic retinopathy continues to be a leading cause of vision impairment worldwide, insights into how standard treatments affect ocular structures beyond the retina contribute to a more comprehensive understanding of diabetes-related eye disease. Ongoing research into the choroid’s response to therapeutic interventions may ultimately inform more nuanced approaches to managing retinal conditions in diabetic patients.